Clin2
NCT07787585Possibly a fitNot yet recruiting

Stopping low-dose thyroid hormone in older adults

Hypothyroidism

Part of Hormones & metabolism clinical trials.

This study looks at whether it is safe to stop taking a low dose of levothyroxine (a thyroid hormone pill) in people aged 65 and older who have a mildly underactive thyroid. If you have been on this medication for at least 6 months, you may be able to help doctors learn if stopping the pill is a good option.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
138 people
Ages
65 years and older
Study type
Interventional

Who can take part

  • You are 65 years of age or older.
  • You have been taking levothyroxine (a thyroid hormone pill) for a mildly underactive thyroid for at least 6 months.
  • Your current daily dose is 50 micrograms (mcg) or less (or 25 mcg or less if you weigh less than 50 kg).
  • Your thyroid levels are normal at the time of joining the study.
  • You have not had thyroid surgery, radioactive iodine treatment, thyroid cancer, or a goiter causing pressure symptoms.
  • You are not taking certain medications that affect thyroid hormone (like amiodarone or lithium).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06073665Recruiting· Phase 4
Thyroid hormone dosing in older adults

This study tests whether current thyroid medication doses are appropriate for people aged 65 and older. The goal is to find the best dose for each person to improve well-being.

Philadelphia, Pennsylvania
NCT06629272Recruiting
Reducing Unnecessary Thyroid Hormone in Older Adults

This study is testing whether it’s safe to slowly reduce or stop thyroid hormone medication in older adults who may not need it. The goal is to improve health and avoid unnecessary treatment.

San Francisco, California
NCT06731764Recruiting· Phase 2/Phase 3
New ways to treat hypothyroidism

This study tests a new approach for people with hypothyroidism who are already taking levothyroxine. You may be able to join if you are on a certain dose and do not have other health conditions that could affect the results.

Farmington, Connecticut
NCT03977207Recruiting
Thyroid hormone supplement for people on dialysis

This trial tests whether taking a thyroid hormone supplement helps people who are on hemodialysis and have borderline-high thyroid lab results (high TSH but normal FT4). It’s studying whether treatment changes thyroid-related outcomes or health while on dialysis.

Orange, California
NCT07421869Recruiting
Recovery from immune therapy-related hypothyroidism

This trial looks at whether patients can recover from low thyroid function caused by immune checkpoint inhibitor drugs. If you've finished immune therapy and are on thyroid medication, you may be able to stop or reduce it.

Seongnam-si
NCT07781514Enrolling by invitation
Vitamin E as an add-on to levothyroxine for hypothyroidism

This trial tests whether adding vitamin E to your usual levothyroxine treatment helps improve thyroid function and reduce oxidative stress (a type of cell damage) in adults with hypothyroidism.

Dhaka

Hear when a new Hypothyroidism trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.